Atossa Genetics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.12.24	Atossa's 1 MG Z-Endoxifen Shows Reduction In Dense Breast Tissue In Premenopausal Women (RTTNews)
12.08.24	Atossa Therapeutics Inc. Q2 Loss Decreases, Beats Estimates (RTTNews)
30.10.23	Quantum Leap Healthcare Collaborative Initiates Landmark Phase 2 RECAST DCIS Platform Trial to Evaluate Alternative DCIS Treatments with Atossa Therapeutics, Havah Therapeutics, and the Menarini Group (PR Newswire)
11.10.23	Fast-food consumption by adolescent girls may sow the seeds of breast cancer decades later (PR Newswire)
14.08.23	Atossa Hits Enrolment Milestones In Three Phase 2 Trials Of Endoxifen In Breast Cancer (RTTNews)
28.06.23	Atossa Therapeutics and Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen Arm of Ongoing I-SPY 2 Clinical Trial (PR Newswire)
11.05.23	Physician-Scientist Dr. Steven Quay Provides Recommendations to the United States Preventive Services Task Force on Breast Cancer Screening Policies and Practices (PR Newswire)
21.03.23	Atossa Therapeutics and Quantum Leap Healthcare Announce New Study Arm to Evaluate (Z)-Endoxifen in the Ongoing I-SPY 2 Clinical Trial (PR Newswire)
16.12.21	Physician-Scientist Steven Quay Calls for International Effort to Investigate a Coronavirus discovered in Laos by Institut Pasteur (PR Newswire)
26.07.21	Physician-Scientist Steven Quay: Forensic examination of Wuhan Institute of Virology COVID-19 patient specimens from December 2019 reveals extensive laboratory contamination, including evidence of... (PR Newswire)
15.07.21	Physician-Scientist Steven Quay and an International Team of Scientists and Investigators Provide Science-Based Analysis of the Origin of COVID-19 to the US Congress (PR Newswire)
28.06.21	Pre-market Movers: NTLA, ABUS, ATOS, GTEC... (RTTNews)
15.06.21	Atossa - Focusing On Breast Cancer & COVID-19 (RTTNews)
26.01.21	AZN Rejects Media Reports, MRK Quits COVID-19 Vaccine Work, MRNA Sets Eyes On New SARS-CoV-2 Strains (RTTNews)
22.01.21	Pre-market Movers In Healthcare Sector: ADMP, FLDM, ATOS, AUPH, SENS... (RTTNews)
07.01.21	Atos Says Approaches DXC Technology For Potential Friendly Transaction (RTTNews)
09.12.20	Pre-market Movers In Healthcare Sector: RCKT, LPCN, PRPH, KZIA, CRIS… (RTTNews)
17.09.20	Atossa Reports Second Favorable Safety Review In Clinical Study Of AT-301 Nasal Spray (RTTNews)
22.07.20	Pre-market Movers In Healthcare Sector: ZOM, BNGO, ATOS, CHEK, TNXP... (RTTNews)
21.05.20	ATRA Abuzz, ATOS' COVID-19 Med Effective, INO And VXRT On Track (RTTNews)
20.05.20	Stock Alert: Atossa Up 28% On Positive Results From Its COVID-19 Drug Candidate (RTTNews)
20.04.20	Atossa Therapeutics Seeks FDA Approval To Launch COVID-19 HOPE Study (RTTNews)
28.06.19	5 Top Gainers In Healthcare Sector (DOVA, ATOS, ZGNX...) (RTTNews)
26.06.19	6 Top Gainers In Healthcare Sector (AGN, XNCR, ATOS…) (RTTNews)
24.04.19	6 Top Gainers In Healthcare Sector (ATOS, AKTX, ATHX...) (RTTNews)
15.03.19	ATOS Skyrockets, BPMX Gets "Going Concern" Warning, Respite For KPTI (RTTNews)
11.01.19	Top 5 Losers In Healthcare Sector (PAVM, ATOS, TBIO...) (RTTNews)
10.01.19	5 Top Gainers In Healthcare Sector (ATOS, AZRX, NSTG...) (RTTNews)
02.09.18	10 Pharma Stocks To Watch This Month (RTTNews)
14.08.18	MBIO & Bubble Boy Disease Gene Therapy, Busy Months Ahead For EIGR, UMRX (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	136.90	1.56 %	K V
Logitech Intl	74.22	1.42 %	K V
Holcim	87.32	1.42 %	K V
Swiss Re	130.25	1.36 %	K V
Roche Hldg G	250.60	1.29 %	K V
Part Grp Hldg	1’218.00	0.58 %	K V
Lonza Grp	534.00	0.56 %	K V
Sonova Hldg	297.10	0.51 %	K V
Nestle	74.02	0.05 %	K V
Geberit	513.80	-0.08 %	K V

Nachrichten zu Atossa Genetics Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten